NAD+ Liposomal on the European supplement market
Most ingredient pages tell you what NAD+ Liposomal is. This one shows how the European supplement market actually uses it — who sells it, who advertises it, and at what price.
RavenBI Market Intelligence · measured 25 Oct 2026 · observed, not estimated. Ad counts are active creatives in Meta's public Ad Library; product and price data come from public listings across the EU and US. Figures change weekly.
RavenBI tracks 239 NAD+ Liposomal products from 121 brands across the EU and US. 73 brands advertise it on Meta right now, and new-ad activity cooled 35% in the last 30 days. United Kingdom shows the heaviest advertising, while United Kingdom has the largest shelf. The median EU shelf price sits around €36.
New NAD+ Liposomal ads launched per month on Meta — last 6 months.
How brands use NAD+ Liposomal, market by market
Products and brands that sell it, active ads and brands that advertise it, and the median shelf price — per market.
| Market | Products | Brands selling | Active ads | Brands advertising | Median price |
|---|---|---|---|---|---|
| Germany | 13 | 10 | 57 | 8 | €32.47 |
| United Kingdom | 91 | 34 | 164 | 14 | £49.95 |
| France | 12 | 9 | 5 | 2 | €39.95 |
| Italy | 7 | 6 | 132 | 4 | €39.99 |
| Spain | 19 | 15 | 37 | 13 | €31.49 |
| Romania | 15 | 8 | 3 | 1 | 202.49 RON |
| United States | 61 | 27 | 68 | 16 | $42.50 |
| Austria | 6 | 3 | 2 | 2 | — |
Who is on the shelf right now
Top brands by number of NAD+ Liposomal products, and the forms they use.
Most-used forms
| Form | Products |
|---|---|
| NADH | 65 |
| Liposomal NAD+ | 41 |
| Nicotinamide adenine dinucleotide | 30 |
| NAD+ lipozomal (reduced) | 28 |
| NAD+ (Nicotinamide adenine dinucleotide) | 27 |
| NAD+ lipozomal (reduced form) | 27 |
Regulatory & positioning
| Botanical source | Nicotinamide adenine dinucleotide |
|---|---|
| Novel food status | Not novel in food supplements |
| EFSA authorized health claims | None authorized |
| Marketed categories (observed) | energy, longevity, brain health |
No EFSA-authorized health claim exists for NAD+ Liposomal, yet brands market it for energy, longevity, brain health — the gap between claim and positioning is itself a competitive signal.
Where NAD+ Liposomal shows up
Across the ad channels and marketplaces RavenBI tracks.
See the ads, listings and shops behind these numbers →
What is NAD+ Liposomal?
NAD+ Liposomal is a coenzyme form of nicotinamide adenine dinucleotide, involved in cellular metabolic processes. It is classified as a coenzyme rather than a vitamin or mineral. The liposomal delivery system is designed to enhance the bioavailability of NAD+. This ingredient is commonly used in dietary supplements marketed for energy, longevity, and brain health. Its inclusion is intended to support formulations targeting cellular function and metabolic activity through improved absorption.
This overview was generated with AI from public information and RavenBI's classification. Informational only, not medical advice.
30,000+ ingredients tracked across the EU + US · Live competitor ads, prices and product claims · Spot under-served demand in each market before rivals do.
Start free trial — full access